Determination of paroxetine in human plasma by high-performance liquid chromatography using 7,7,8,8-tetracyanoquinodimethane as the derivatization reagent

Therapeutic Drug Monitoring

Volumn 28, Issue 2, 2006, Pages 180-184

  Önal, Armaǧan ^a   Öztunç, Aysel ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

HPLC; Paroxetine; Pharmacokinetics; TCNQ

Indexed keywords

7,7,8,8 TETRACYANOQUINODIMETHANE; ACETONITRILE; ANTIDEPRESSANT AGENT; CHLOROFORM; DESIPRAMINE; PAROXETINE; REAGENT; UNCLASSIFIED DRUG;

ADULT; ALKALINIZATION; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DERIVATIZATION; DEVICE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL NOISE RATIO; TEMPERATURE DEPENDENCE;

ADMINISTRATION, ORAL; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MOLECULAR STRUCTURE; NITRILES; PAROXETINE; REPRODUCIBILITY OF RESULTS; SEROTONIN UPTAKE INHIBITORS; TABLETS;

EID: 33748204491     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000185768.36878.49     Document Type: Article

References (32)

1. Morton I, Hall J. Medicines: The Comprehensive Guide, 2nd ed. London: Bloomsbury; 1991:23.
2. Bourin M, Chue P, Guillon Y. Paroxetine: a review. CNS Drug Rev. 2001;7:25-47.
3. Sindrup SH, Brosen K, Gram LF. Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: nonlinearity and relation to the sparteine oxidation polymorphism. Clin Pharmacol Ther. 1992;51:288-295.
4. Sindrup SH, Brosen K, Gram LF, et al. The relationship between paroxetine and the sparteine oxidation polymorphism. Clin Pharmacol Ther. 1992;51:278-287.
5. Bloomer JC, Woods FR, Haddock RE, et al. The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes. Br J Clin Pharmacol. 1992;33:521-523.
6. Gupta RM. Drug level monitoring: antidepressants. J Chromatogr. 1992;576:183-211. and references cited therein.
7. Knoeller J, Vogt-Schenkei R, Brett MA. A simple and robust HPLC method for the determination of paroxetine in human plasma. J Pharm Biomed. 1995;13:635-638.
8. Foglia PJ, Sorisio D, Kirshner M, et al. Quantitative determination of paroxetine in plasma by high performance liquid chromatography and ultraviolet detection. J Chromatogr B. 1997;693:147-151.
9. Skibinski R, Mistzal G, Olajassy M. High-performance liquid chromatographic determination of fluvoxamine and paroxetine in plasma. Chem Anal (Warsaw). 2000;45:815-823.
10. Zainaghi IA, Lanchote VL, Queiroz RHC. Determination of paroxetine in geriatric depression by high-performance liquid chromatography. Pharmacol Res. 2003;48:217-221.
11. Tournel G, Houdret NM, Deveaux VH, et al. High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum. J Chromatogr B. 2001;761:147-158.
12. Frahnert C, Rao ML, Grasmader K. Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring. J Chromatogr B Anal Technol Biomed Life Sci. 2003;794:35-47.
13. Shin J-G, Kim K-A, Yoon Y-R, et al. Rapid simple high-performance liquid chromatographic determination of paroxetine in human plasma. J Chromatogr B. 1998;713:452-456.
14. Lopez-Calull C, Dominguez N. Determination of paroxetine in plasma by high-performance liquid chromatography for bioequivalance studies. J Chromatogr B. 1999;724:393-398.
15. Gupta RN. Column liquid chromatographic determination of paroxetine in human serum using solid-phase extraction. J Chromatogr B. 1994;661:362-365.
16. Brett MA, Dierdorf BHD, Zussman D, et al. Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection. J Chromatogr B. 1987;419:438-444.
17. Lacassie E, Gaulier J-M, Marquet P, et al. Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography. J Chromatogr B. 2000;742:229-238.
18. Lucca A, Gentilini G, Lopez-Silva S, et al. Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography. Ther Drug Monit. 2000;22:271-276.
19. Lai CT, Gordon ES, Kennedy SH, et al. Determination of paroxetine levels in human plasma using gas chromatography with electron capture detection. J Chromatogr B. 2000;749:275-279.
20. Eap CB, Bouchoux G, Amey M, et al. Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline and their metabolites by gas chromatography-mass spectrometry. J Chromatogr Sci. 1998;36:365-371.
21. Labat L, Deveaux M, Dallet P, et al. Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. J Chromatogr B. 2002;773:17-23.
22. Kaye CM, Haddock RE, Langley PF, et al. A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand. 1989;80:60-75.
23. Kristoffersen L, Bugge A, Lundanes E, et al. Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high performance liquid chromatography with ultraviolet and fluorescence detection. J Chromatogr B. 1999;734:229-246.
24. Saleh GA. Charge-transfer complexes of barbiturates and phenytoin. Talanta. 1998;46:111-121.
25. Abdel-Gawad FM, Issa YM, Fahmy HM, et al. Spectrophotometric determination of ciprofloxacin in pure form and in tablets through charge-transfer complexation reactions. Microchim Acta. 1998;130:35-40.
26. Abdellatef HE. Utility of certain π-acceptors for the spectrophotometric determination of perindopril. J Pharm Biomed Anal. 1998;17:1267-1271.
27. Kovar KA, Mayer W, Auterhoff H. Molecular complexes and radicals of procaine. Arch Pharmacol. 1981;314:447-458.
28. Kovar KA, Abdel-Hamid ME. Charge-transfer complexes formation in drug analysis. Arch Pharmacol. 1984;317:246-256.
29. Hussein SA, Mohamed AM, Abdel-Alim M. Utility of certain π-acceptors for the spectrophotometric determination of gliclazide and tolazamide. Analyst. 1989;114:1129-1131.
30. Öztunç A, Önal A, Erturk S. 7,7,8,8- Tetracyanoquinodimethane as a new derivatization reagent for high-performance liquid chromatography and thin-layer chromatography: rapid screening of plasma for some antidepressants. J Chromatogr B. 2002;774:149-155.
31. Hertler WR, Hartzler HD, Acker DS, et al. Substituted quinodimethans. III. Displacement reactions of 7,7,8,8-tetracyanoquinodimethane. J Am Chem Soc. 1962;84:3387-3393.
32. Lambropoulos J, Spanos GA, Lozaridis NV. Method development and validation for the HPLC assay (potency and related substances) for 20 mg paroxetine tablets. J Pharm Biomed Anal. 1999;19:793-802.